Penumbra vs Dr. Reddy's Laboratories

Penumbra (PEN), health care, and Dr. Reddy's Laboratories (RDY), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Penumbra is worth $12.6B on the stock market and Dr. Reddy's Laboratories $12.3B: Penumbra is valued at 2% more. Penumbra trades at 80.4 times earnings and Dr. Reddy's Laboratories at 41.1; operating margins in their latest fiscal years were 13.5% and 15.0%. Over the past year Penumbra's share price has moved +15.3% and Dr. Reddy's Laboratories's +4.85%.

Key facts

Penumbra market value
$12.6B
Dr. Reddy's Laboratories market value
$12.3B
Penumbra P/E
80.4
Dr. Reddy's Laboratories P/E
41.1
Penumbra revenue
$1.4BFY to 2025-12-31
Dr. Reddy's Laboratories revenue
$3.6BFY to 2026-03-31
Superinvestors holding both
0

Market values as of .

Penumbra vs Dr. Reddy's Laboratories: every measure side by side
Measure Penumbra Dr. Reddy's Laboratories
SectorHealth CareHealth Care
Country United States India
Fiscal year ends2025-12-312026-03-31
Size
Market cap$12.6Bhigher$12.3Blower
Revenue$1.4Blower$3.6Bhigher
Earnings$177.7Mlower$456Mhigher
Employees4,700lower27,527higher
Total assets$1.8Blower$6.2Bhigher
Valuation
P/E80.4higher41.1lower
P/S9.0higher3.4lower
P/B7.9—
Dividend yield0.00%—
Profitability
Operating margin13.5%lower15.0%higher
Balance sheet
Net assets$1.4Blower$4Bhigher
Total liabilities$398.9Mlower$2.1Bhigher
Total debt—$193.7M
Cash on hand$186.9Mhigher$163.5Mlower
Price change
Today-0.47%lower+0.61%higher
1 year+15.3%higher+4.85%lower

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

Loading the one-year price chart…

Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

Both (0)

None of the tracked investors.

Penumbra only (2)

Dr. Reddy's Laboratories only (0)

None of the tracked investors.

Percentages are each holding's share of that investor's reported portfolio. Who owns PEN · Who owns RDY

Further comparisons

Learn

Questions and answers

Which is bigger, Penumbra or Dr. Reddy's Laboratories?

By market value, Penumbra is the larger: $12.6B against $12.3B for Dr. Reddy's Laboratories. By revenue in its latest fiscal year, Dr. Reddy's Laboratories is the larger: $3.6B against $1.4B for Penumbra.

Which has the higher P/E ratio?

Penumbra: 80.4, against 41.1 for Dr. Reddy's Laboratories. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.

Which has the higher operating margin?

Dr. Reddy's Laboratories: 15.0%, against 13.5% for Penumbra. Operating margin is operating income as a share of revenue in the latest fiscal year.

Which superinvestors own both Penumbra and Dr. Reddy's Laboratories?

None of the tracked superinvestors holds both in their latest 13F filing. 2 hold Penumbra and 0 hold Dr. Reddy's Laboratories.

Cite this page

Funkfolio, “Penumbra vs Dr. Reddy's Laboratories”, data as of 18 November 2026. https://funkfolio.com/compare/pen-vs-rdy

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.